122 related articles for article (PubMed ID: 2252123)
1. Increased septic complications with three-drug sequential immunosuppression for cadaver renal transplants.
Thayer C; Bartlett ST; Ward RE
Am J Surg; 1990 Dec; 160(6):614-7. PubMed ID: 2252123
[TBL] [Abstract][Full Text] [Related]
2. Sequential antilymphocyte globulin/cyclosporine immunosuppression in cadaveric renal transplantation. Effect of duration of ALG therapy.
Stratta RJ; D'Alessandro AM; Armbrust MJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO
Transplantation; 1989 Jan; 47(1):96-102. PubMed ID: 2643236
[TBL] [Abstract][Full Text] [Related]
3. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients.
Boudreaux JP; McHugh L; Canafax DM; Ascher N; Sutherland DE; Payne W; Simmons RL; Najarian JS; Fryd DS
Transplantation; 1987 Sep; 44(3):376-81. PubMed ID: 3307061
[TBL] [Abstract][Full Text] [Related]
4. Comparison of kidney transplant survival between patients treated with cyclosporine and those treated with azathioprine and antithymocyte globulin.
Cho SI; Bradley JW; Monaco AP; Tilney NL
Am J Surg; 1984 Apr; 147(4):518-23. PubMed ID: 6370008
[TBL] [Abstract][Full Text] [Related]
5. A comparison of two cyclosporine protocols at the University of Minnesota.
Fryd DS; Canafax DM; Matas AJ; Dunn D; Payne WD; Sutherland DE; Najarian JS
Clin Transpl; 1988; ():79-90. PubMed ID: 3154498
[TBL] [Abstract][Full Text] [Related]
6. The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine.
Canafax DM; Torres A; Fryd DS; Heil JE; Strand MH; Ascher NL; Payne WD; Sutherland DE; Simmons RL; Najarian JS
Transplantation; 1986 Feb; 41(2):177-81. PubMed ID: 3511581
[TBL] [Abstract][Full Text] [Related]
7. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
8. A comparison of triple-therapy with double-therapy immunosuppression in cadaveric renal transplantation.
Bowman JS; Angstadt JD; Waymack JP; Jaffers GJ
Transplantation; 1992 Mar; 53(3):556-9. PubMed ID: 1312752
[TBL] [Abstract][Full Text] [Related]
9. Comparison of antilymphocyte globulin and continuous i.v. cyclosporine A as induction immunosuppression for cadaver kidney transplants: a prospective randomized study.
Belitsky P; MacDonald AS; Cohen AD; Crocker J; Hirsch D; Jindal K; Lawen J
Transplant Proc; 1991 Feb; 23(1 Pt 2):999-1000. PubMed ID: 1989359
[No Abstract] [Full Text] [Related]
10. Sequential therapy in pediatric cadaveric renal transplantation: a critical analysis.
Ettenger R; Marik J; Rosenthal JT
J Am Soc Nephrol; 1992 Jun; 2(12 Suppl):S304-11. PubMed ID: 1498290
[TBL] [Abstract][Full Text] [Related]
11. Improved results of cadaver renal transplantation with azathioprine, prednisone and antilymphoblast globulin.
Novick AC; Khauli RB; Braun WE; Steinmuller D; Cunningham R; Buszta C; Goormastic M
J Urol; 1984 Apr; 131(4):636-40. PubMed ID: 6368866
[TBL] [Abstract][Full Text] [Related]
12. Cadaveric renal transplant without prophylactic prednisone therapy.
Bry W; Warvariv V; Bohannon L; Feduska N; Straube B; Collins G; Levin B
Transplant Proc; 1991 Feb; 23(1 Pt 2):994-6. PubMed ID: 1989357
[No Abstract] [Full Text] [Related]
13. A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
Najarian JS; Fryd DS; Strand M; Canafax DM; Ascher NL; Payne WD; Simmons RL; Sutherland DE
Ann Surg; 1985 Feb; 201(2):142-57. PubMed ID: 3882063
[TBL] [Abstract][Full Text] [Related]
14. [4-way immunosuppression in pre-sensitized recipients of allogenic cadaver kidney transplants].
Oesterwitz H; May G; Müller P; Strobelt V; Seeger W; Seibt F; Horlbeck R; Hansen C
Z Urol Nephrol; 1990 Jan; 83(1):1-8. PubMed ID: 2184625
[TBL] [Abstract][Full Text] [Related]
15. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation?
Posner MP; Mendez-Picon G; King A; Nelson KP; Spicer HG; Lee HM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519
[No Abstract] [Full Text] [Related]
16. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years.
Canadian Multicentre Transplant Study Group
N Engl J Med; 1986 May; 314(19):1219-25. PubMed ID: 2871486
[TBL] [Abstract][Full Text] [Related]
17. Low-dose cyclosporine therapy combined with standard immunosuppression in pediatric renal transplantation.
So SK; Najarian JS; Nevins TE; Fryd DS; Knaak M; Chavers B; Mauer SM; Simmons RL
J Pediatr; 1987 Dec; 111(6 Pt 2):1017-21. PubMed ID: 3316573
[TBL] [Abstract][Full Text] [Related]
18. Comparison of three immunosuppressive regimens in cadaver renal transplantation: long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine.
Hall BM; Tiller DJ; Hardie I; Mahony J; Mathew T; Thatcher G; Miach P; Thomson N; Sheil AG
N Engl J Med; 1988 Jun; 318(23):1499-507. PubMed ID: 3285215
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporin treatment with conversion after three months versus conventional immunosuppression in renal allograft recipients.
Hoitsma AJ; Wetzels JF; van Lier HJ; Berden JH; Koene RA
Lancet; 1987 Mar; 1(8533):584-6. PubMed ID: 2881130
[TBL] [Abstract][Full Text] [Related]
20. Sequential use of Minnesota antilymphoblast globulin and cyclosporine in cadaveric renal transplantation.
Kupin WL; Venkatachalam KK; Oh HK; Dienst S; Levin NW
Transplantation; 1985 Dec; 40(6):601-4. PubMed ID: 3907029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
